Georgy Genov
European Medicines Agency(NL)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life, Meta-analysis and systematic reviews, Pharmaceutical studies and practices
Most-Cited Works
- → Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works(2017)137 cited
- → Balancing benefit and risk of medicines: a systematic review and classification of available methodologies(2014)118 cited
- → Patient Reporting in the EU: Analysis of EudraVigilance Data(2017)80 cited
- → Myocarditis associated with COVID-19 vaccination(2024)56 cited
- → A Description of Signals During the First 18 Months of the EMA Pharmacovigilance Risk Assessment Committee(2014)55 cited
- → Improving the Safety of Medicines in the European Union: From Signals to Action(2019)50 cited
- → Safety Monitoring of COVID‐19 Vaccines: Perspective from the European Medicines Agency(2022)38 cited
- → Literature review of visual representation of the results of benefit–risk assessments of medicinal products(2015)33 cited
- → What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?(2020)16 cited
- → COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance(2024)10 cited